WallStreetZenWallStreetZen

NASDAQ: ITCI
Intra Cellular Therapies Inc Stock Ownership - Who owns Intra Cellular Therapies?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Intra Cellular Therapies Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Rory B. RiggsDirector2024-03-31260$69.20
$17.99kBuy
Nostrand Robert L. VanDirector2024-03-3179$69.20
$5.47kBuy
Rory B. RiggsDirector2024-03-2020,000$18.56
$371.20kBuy
Lawrence J. HinelineSVP of Finance CFO2024-03-1164$67.12
$4.30kSell
Mark NeumannEVP Chief Commercial Officer2024-03-114,303$65.11
$280.17kSell
Michael HalsteadEVP and General Counsel2024-03-116,107$65.82
$401.96kSell
Lawrence J. HinelineSVP of Finance CFO2024-03-1129$67.32
$1.95kSell
Lawrence J. HinelineSVP of Finance CFO2024-03-114,475$66.47
$297.45kSell
Suresh K. DurgamEVP Chief Medical Officer2024-03-11661$66.96
$44.26kSell
Suresh K. DurgamEVP Chief Medical Officer2024-03-11872$65.89
$57.46kSell

1 of 12

ITCI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITCI insiders and whales buy or sell their stock.

ITCI Shareholders

What type of owners hold Intra Cellular Therapies Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.84%11,457,694$847.98MInstitution
Vanguard Group Inc9.39%9,094,302$673.07MInstitution
Blackrock Inc8.46%8,193,544$606.40MInstitution
Christopher D. Alafi6.05%5,859,318$433.65MInsider
Nlbdit 2010 Services LLC5.16%5,000,000$370.05MInsider
Moshe Alafi4.08%3,953,270$292.58MInsider
Alafi Capital Co LLC4.08%3,953,270$292.58MInsider
Morton I. Sosland3.76%3,638,389$269.28MInsider
Wasatch Advisors LP3.75%3,627,308$268.46MInstitution
Bellevue Group Ag3.17%3,066,400$226.94MInstitution

1 of 3

ITCI vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITCI78.46%21.54%Net SellingNet Selling
ELAN90.53%9.47%Net SellingNet Selling
LNTH53.56%46.44%Net SellingNet Selling
PRGO61.54%38.46%Net SellingNet Buying
ALKS93.61%6.39%Net SellingNet Selling
View Top Pharmaceutical Stocks

Intra Cellular Therapies Stock Ownership FAQ

Who owns Intra Cellular Therapies?

Intra Cellular Therapies (NASDAQ: ITCI) is owned by 92.27% institutional shareholders, 25.33% Intra Cellular Therapies insiders, and 0.00% retail investors. Christopher D. Alafi is the largest individual Intra Cellular Therapies shareholder, owning 5.86M shares representing 6.05% of the company. Christopher D. Alafi's Intra Cellular Therapies shares are currently valued at $428.43M.

If you're new to stock investing, here's how to buy Intra Cellular Therapies stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.